We are live on ! Find out more
CAH icon

Cardinal Health

718 hedge funds and large institutions have $11.6B invested in Cardinal Health in 2018 Q4 according to their latest regulatory filings, with 131 funds opening new positions, 202 increasing their positions, 281 reducing their positions, and 88 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more call options, than puts

Call options by funds: $110M | Put options by funds: $71.5M

49% more first-time investments, than exits

New positions opened: 131 | Existing positions closed: 88

5% more funds holding

Funds holding: 685718 (+33)

0.75% more ownership

Funds ownership: 87.23%87.97% (+0.75%)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

20% less capital invested

Capital invested by funds: $14.5B → $11.6B (-$2.9B)

28% less repeat investments, than reductions

Existing positions increased: 202 | Existing positions reduced: 281

Holders
718
Holders Change
+33
Holders Change %
+4.82%
% of All Funds
16%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
131
Increased
202
Reduced
281
Closed
88
Calls
$110M
Puts
$71.5M
Net Calls
+$38.7M
Net Calls Change
+$51M
Name Holding Trade Value Shares
Change
Change in
Stake
Ohio Public Employees Retirement System (OPERS)
151
Ohio Public Employees Retirement System (OPERS)
Ohio
$5.25M -$156K -2,998 -2%
Aviva
152
Aviva
United Kingdom
$5.17M -$1.82M -34,945 -23%
Arrowstreet Capital
153
Arrowstreet Capital
Massachusetts
$4.76M -$8.85M -169,788 -61%
KBC Group
154
KBC Group
Belgium
$4.75M -$221K -4,245 -4%
OPERF
155
Oregon Public Employees Retirement Fund
Oregon
$4.7M +$606K +11,617 +12%
N
156
Natixis
France
$4.7M -$11M -210,534 -67%
EP
157
Elkfork Partners
Oregon
$4.66M -$1.12M -21,488 -17%
GWM
158
Geneos Wealth Management
Colorado
$4.59M -$139K -2,658 -3%
Man Group
159
Man Group
United Kingdom
$4.57M -$18M -345,823 -77%
Nomura Asset Management
160
Nomura Asset Management
Japan
$4.52M +$621K +11,920 +13%
Zurich Cantonal Bank
161
Zurich Cantonal Bank
Switzerland
$4.5M +$275K +5,280 +6%
TD Asset Management
162
TD Asset Management
Ontario, Canada
$4.49M -$34.5K -662 -0.7%
BNP Paribas Asset Management
163
BNP Paribas Asset Management
France
$4.44M +$3.86M +74,017 +289%
CFG
164
Cambridge Financial Group
Ohio
$4.43M +$149K +2,851 +3%
BCM
165
BlueCrest Capital Management
Jersey
$4.41M +$4.21M +80,808 +447%
KFP
166
Keystone Financial Planning
Ohio
$4.38M +$164K +3,154 +3%
CWM
167
CIBC World Markets
New York
$4.31M -$1.24M -23,873 -20%
Comerica Bank
168
Comerica Bank
Texas
$4.31M -$136K -2,605 -3%
PG
169
Pendal Group
Australia
$4.29M +$6.05M +116,093 New
JFL
170
Jarislowsky, Fraser Ltd
Quebec, Canada
$4.28M -$1.24M -23,755 -20%
Lord, Abbett & Co
171
Lord, Abbett & Co
New Jersey
$4.24M -$22M -421,900 -82%
AG
172
Advisor Group
Arizona
$4.14M +$924K +17,721 +24%
SSA
173
Schonfeld Strategic Advisors
New York
$4M +$4.67M +89,639 New
RJA
174
Raymond James & Associates
Florida
$3.89M -$112K -2,152 -2%
NCM
175
Novare Capital Management
North Carolina
$3.88M +$2.07M +39,742 +84%

CAH Hedge Fund Activity: Q4 2018 in Review

718 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q4 2018, worth a combined $11.6B — down 20% from $14.5B a quarter earlier.

Buyers outnumbered sellers: 131 funds opened new CAH positions and 88 closed out — a net gain of 43 holders — while 202 added to existing stakes and 281 trimmed.

The largest buyer was AQR Capital Management, adding an estimated $124M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $454M.

  • 718 institutional investors held Cardinal Health (CAH) as of Q4 2018, up from 685 in Q3 2018.
  • Funds reported $11.6B of Cardinal Health stock for Q4 2018, down 20% quarter-over-quarter.
  • 131 funds opened new Cardinal Health positions in Q4 2018 and 88 closed out, a net change of +43 holders.
  • The largest Cardinal Health buyer in Q4 2018 was AQR Capital Management, an estimated $124M added.
  • The largest Cardinal Health seller in Q4 2018 was Barrow, Hanley, Mewhinney & Strauss, an estimated $454M sold.

Based on aggregated 13F filings for Q4 2018.